calendar
63 catalysts · 3,921 phase readout · 2,127 8k filing · 277 earnings · 172 phase 2 completion · 133 drug shortage · 109 grant
63 catalysts · 3,921 phase readout · 2,127 8k filing · 277 earnings · 172 phase 2 completion · 133 drug shortage · 109 grant
Therapy area: Oncology. Indication: Metastatic Pancreatic Cancer, Pancreatic Cancer
Therapy area: Central Nervous System, Respiratory. Indication: Pleural Disease, Post-Operative Pain
Therapy area: Immunology, Respiratory. Indication: Allergic Rhinitis, Inflammation, Transplant Rejection
Therapy area: Immunology. Indication: Kidney Transplant Rejection
Therapy area: Cardiovascular. Indication: Hypotension
Therapy area: Immunology. Indication: Cutaneous Lupus Erythematosus, Systemic Lupus Erythematosus
Therapy area: Gastrointestinal, Genito Urinary System, Infectious Disease. Indication: Gonorrhea, Intestinal Infection, Salmonella Infections, Typhoid Fever, Urinary Tract Infections
Therapy area: Central Nervous System. Indication: Post-Operative Pain
Therapy area: Oncology. Indication: Multiple Myeloma (Kahler Disease), Refractory Multiple Myeloma
Therapy area: Oncology, Toxicology. Indication: Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome), Colon Tumor
Therapy area: Respiratory. Indication: Idiopathic Pulmonary Fibrosis, Interstitial Lung Fibrosis
Therapy area: Infectious Disease. Indication: Hepatitis B
This page contains notices of advisory committee meetings. Refer to the individual meeting link below for more information on the anticipated format of each meeting. For previous years' advisory committee calendars, see the FDA Archive.